Patient Outcomes Archives - The Office of Health Economics (OHE)

Search the Knowledge Hub

Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment Do Adult and Adolescent Preferences Differ

Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?

Mott, D.J., Shah, K.K., Ramos-Goñi, J.M., Devlin, N.J. and Rivero-Arias, O.

Methods for Analysing and Reporting EQ-5D Data

Devlin, Nancy, Parkin, David, Janssen, Bas

#Book,
#Patient Outcomes,

Testing the validity and responsiveness of a new cancer-specific health utility measure FACT-8D in relapsed refractory mantle cell lymphoma and comparison to EQ-5D-5L

Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L

Herdman, M., Kerr, C., Pavesi, M., Garside, J., Lloyd, A., Cubi-Molla, P. & Devlin, N.

Drop Dead Is Anchoring at Dead a Theoretical Requirement in Health State Valuation

Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation?

Sampson, C., Parkin, D. and Devlin, N.

An exploration of methods for obtaining 0 dead anchors for latent scale EQ-5D-Y values

An exploration of methods for obtaining 0= dead anchors for latent scale EQ-5D-Y values

Shah, K.K., Ramos-Goñi, J.M., Kreimeier, S. and Devlin, N.J.

International Valuation Protocol for the EQ-5D-Y-3L

Ramos-Goñi, J.M., Oppe, M., Stolk, E., Shah, K., Kreimeier, S., Rivero-Arias, O. & Devlin, N

NICE and EuroQol Research Foundation to Support New EQ-5D-5L Valuation Study

Nancy Devlin, Koonal Shah, Yan Feng

#Blog,
#Patient Outcomes,

OHE is Leading Research to Develop EQ-5D ‘Bolt-ons’ for Cognition and Vision

Chris Sampson

#Blog,
#Patient Outcomes,

Adult Versus Adolescent Preferences for EQ-5D-Y Health States

Koonal Shah

#Blog,
#Patient Outcomes,

Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA

Devlin, N., Lorgelly, P. and Herdman, M.

How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy

Sampson, C. and Garau, M.

Distribution of the EQ-5D-5L Profiles and Values in Three Patient Groups

Feng, Y., Devlin, N., Bateman, A., Zamora, B., and Parkin, D.

End of Life Treatments, Societal Values, and ‘Overall’ Preference

Koonal Shah

#Blog,
#Patient Outcomes,

Generating Preference-based Values for the EQ-5D-Y to Support Its Use in HTA

Koonal Shah

#Blog,
#Patient Outcomes,

A note on the relationship between age and health-related quality of life assessment

Cubi-Molla, P., Shah, K.K., Garside, J., Herdman, M. and Devlin, N

Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective

Kreimeier, S., Oppe, M., Ramos-Goñi, J.M., Cole, A., Devlin, N., Herdman, M., Mulhern, B., Shah, K.K., Stolk, E., Rivero-Arias, O. & Greiner, W.

Two New Papers on EQ-5D-5L Valuation in Ireland

Koonal Shah

#Blog,
#Patient Outcomes,

A new method for valuing health: directly eliciting personal utility functions

Devlin, N., Shah, K., Mulhern, B., Pantiri, K. and van Hout, B.

Conducting a Time Trade-off Study Alongside a Clinical Trial: A Case Study and Recommendations

Shen, J., Hill, S., Mott, D., Breckons, M., Vale, L. & Pickard, R

Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology

Cubi-Molla, P., Mott, D., Shah, K., Herdman, M., Summers, Y. and Devlin, N.

A New Online Tool for Creating Personal and Social EQ-5D-5L Value Sets

Nancy Devlin

#Blog,
#Patient Outcomes,

Challenges in Valuing Temporary Health States for Economic Evaluation: A Review of Empirical Applications of the Chained Time Trade-Off Method

Stoniute, J., Mott, D.J. & Shen, J

New Methods for Analysing the Distribution of EQ-5D Observations

Zamora, B., Parkin, D., Feng, Y., Bateman, A., Herdman, M., and Devlin, N.

Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets

Mulhern, B., Feng, Y., Shah, K., van Hout, B., Janssen, B., Herdman, M. and Devlin, N.

Comparing Preference-based Outcome Measures for Overactive Bladder: EQ-5D-5L vs OAB-5D

Herdman, M., Nazir, J., Hakimi, J., Siddiqui, E., Huang, M., Pavesi, M., MacDiamid, S., Drake, M.J., and Devlin, N

#Blog,
#Patient Outcomes,

A New Way of Presenting Health States in Valuation Studies

Cole, A., Shah, K., Mulhern, B., Feng, Y. and Devlin, N

#Blog,
#Patient Outcomes,

Effect of Religion on the Perception of Health States: A Qualitative Study

Elbarazi, I., Devlin, N.J., Katsaiti, M.S., Papadimitropoulos, E.A., Shah, K.K. and Blair, I.

#Blog,
#Patient Outcomes,

Valuing health-related quality of life: An EQ-5D-5L value set for England

Devlin, N., Shah, K., Feng, Y., Mulhern, B. and Van Hout, B.

New methods for modelling EQ-5D-5L value sets: An application to English data

Feng, Y., Devlin, N., Shah, K., Mulhern, B. and Van Hout, B.

Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial. Health and quality of life outcomes.

Devlin, N., Herdman, M., Pavesi, M., Phung, D., Naidoo, S., Beer, T.M., Tombal, B., Loriot, Y., Ivanescu, C., Parli, T., Balk, M. & Holmstrom, S

An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D

Feng, Y., Herdman, M., van Nooten, F., Cleeland, C., Parkin, D., Ikeda, S., Igarashi, A. & Devlin, N.J

What is the Normative Basis for Selecting the Measure of ‘Average’ Preferences for Use in Social Choices?

Devlin, N., Shah, K.K., and Buckingham, K.

Comparing the Cancer-Specific EORTC-8D and the Generic EQ-5D-3L

Lorgelly, P.K., Doble, B., Rowen, D. Brazier, J

#Blog,
#Patient Outcomes,

Important Aspects of Health Not Captured by EQ-5D: Views of the UK General Public

Shah, K., Mulhern, B., Longworth, L. and Janssen, B.

The Application of Anchoring Vignettes to the EQ-5D-5L: A Possible Solution to Reporting Heterogeneity in PROMs

Paula Lorgelly

#Blog,
#Patient Outcomes,

What Determines the Shape of an EQ-5D Index Distribution?

Parkin, D., Devlin, N. and Feng, Y.

Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines: A Systematic Review

Herdman, M., Cole, A., Hoyle, C.K., Coles, V., Carroll, S. & Devlin, N

5 Things You Should Do with EQ-5D Data

Nancy Devlin

#Blog,
#Patient Outcomes,

An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate Health State Values in the United Arab Emirates

Papadimitropoulos, M., Elbarazi, I., Blair, I., Katsaiti, M.S., Shah, K. and Devlin, N.

Adjusting Patient Case Mix to Compare PROMs across Providers

Nuttall, D., Parkin, D. and Devlin, N

#Blog,
#Patient Outcomes,

Assessing the Performance of the EQ-VAS in the NHS PROMs Programme

Feng, Y., Parkin, D. and Devlin, N.

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

Herdman, M., Gudex, C., Lloyd, A., Janssen, M.F., Kind, P., Parkin, D., Bonsel, G. & Badia, X.

Development of the EQ-5D-Y: a child-friendly version of the EQ-5D

Wille, N., Badia, X., Bonsel, G., Burström, K., Cavrini, G., Devlin, N., Egmar, A.-C., Greiner, W., Gusi, N., Herdman, M. & Others

Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Quality of life research

Ravens-Sieberer, U., Wille, N., Badia, X., Bonsel, G., Burström, K., Cavrini, G., Devlin, N., Egmar, A.-C., Gusi, N., Herdman, M. & Others

Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making

Devlin, N. and Appleby, J.

Get Technical Assistance